R.S. IPRATROP 1.25 

Levosalbutamol & Ipratropium Bromide Respiratory Solution

R.S. IPRATROP 1.25  is a specialized respiratory solution combining two potent bronchodilators: Levosalbutamol and Ipratropium Bromide. This formulation is designed to provide effective relief for individuals suffering from obstructive airway diseases, such as chronic obstructive pulmonary disease (COPD) and asthma. By working synergistically, these components help open up the airways, ease breathing, and improve overall respiratory function. This article explores the uses, dosage, side effects, and other essential aspects of R.S. IPRATROP 1.25.

Uses of R.S. IPRATROP 1.25

R.S. IPRATROP 1.25 is primarily used for managing respiratory conditions characterized by narrowed or obstructed airways. These include:

• Chronic Obstructive Pulmonary Disease (COPD): The combination of Levosalbutamol and Ipratropium Bromide helps relax and widen the airways, making it easier to breathe.
• Asthma: A condition where the airways become inflamed and constricted. R.S. IPRATROP 1.25 helps reduce bronchospasm (sudden constriction of the muscles of the airways) and alleviate asthma symptoms.
• Other Obstructive Airway Disorders: It may also be used in conditions where airway obstruction is present, providing symptomatic relief.

Dosage and Administration

The dosage of R.S. IPRATROP 1.25 is tailored to the individual’s specific needs and the severity of their condition. 

• Typical Dosage: The standard dosage is 2.5 ml of the solution administered through a nebulizer, typically 3-4 times a day.
• Administration: It’s essential to follow the healthcare provider’s instructions precisely to ensure the proper dosage and frequency. Overuse or misuse can lead to side effects or reduced efficacy.

Mechanism of Action

R.S. IPRATROP 1.25 works through a combination of Levosalbutamol and Ipratropium Bromide, each contributing to bronchodilation in different ways:

• Levosalbutamol: A selective beta-2 adrenergic agonist that relaxes bronchial smooth muscles by stimulating beta-2 receptors. This leads to dilation of the airways, making it easier for air to flow through.
• Ipratropium Bromide: An anticholinergic agent that inhibits the action of acetylcholine on muscarinic receptors in the airways. This helps reduce bronchoconstriction and mucus secretion, further facilitating easier breathing.

By combining these two mechanisms, R.S. IPRATROP 1.25 provides a comprehensive approach to managing airway constriction and improving respiratory function.

Side Effects

While R.S. IPRATROP 1.25 is effective in managing respiratory conditions, it may cause side effects in some individuals. Common side effects include:

• Dry Mouth: A common side effect of anticholinergic medications like Ipratropium Bromide.
• Cough: Some patients may experience coughing as a reaction to the inhaled mist.
• Headache: May occur due to systemic absorption of the medication.
• Tremors or Palpitations: Less common but can occur due to the beta-agonist effect of Levosalbutamol.

 These may include allergic reactions, severe breathing difficulties, or signs of heart problems.

Price and Availability

The price of R.S. IPRATROP 1.25 can vary based on location and pharmacy. In India, the cost is typically around ₹300-₹400 for a 30 ml bottle, but prices may differ. 

Conclusion

R.S. IPRATROP 1.25 is an effective respiratory solution combining Levosalbutamol and Ipratropium Bromide to manage obstructive airway diseases. Its dual mechanism of action provides comprehensive relief from symptoms associated with COPD and asthma, improving quality of life for individuals with chronic respiratory conditions. Proper dosage and adherence to medical advice are crucial for maximizing benefits and minimizing side effects.  By integrating this solution into a comprehensive treatment plan, patients can achieve better control over their respiratory conditions and enjoy an improved ability to breathe comfortably. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW